🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a single-center, single-dose, open-label clinical study. 12 subjec...
Status
Completed
Location
The Third Hospital of Changsha
Start Date
2022-09-26
Trial ID
NCT05828485
Treatments Being Tested
This is a multicenter, single-arm, open-label study to characterize long-te...
Status
Recruiting
Location
Chinese Academy of Medical Sciences Hematology Hospital (Institute of Hematology, Chinese Academy of Medical Sciences)
Start Date
2024-11-30
Trial ID
NCT06933914
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of MY008211A in ...
Status
Completed
Location
Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2023-07-06
Trial ID
NCT06050226
Treatments Being Tested
Efficacy and safety of MY008211A in IgAN patients...
Status
Not Yet Recruiting
Location
Peking University First Hospital
Start Date
2024-12-31
Trial ID
NCT06687174
Treatments Being Tested
This is a single-center, randomized, double-blind, placebo-controlled, dose...
Status
Completed
Location
The Third Hospital of Changsha
Start Date
2023-01-10
Trial ID
NCT05828472
Treatments Being Tested
The trial is the first human trial. The safety, tolerability, PK and PD of ...
Status
Completed
Location
The Third Hospital of Changsha
Start Date
2022-05-27
Trial ID
NCT05642585
Treatments Being Tested
This study is a single-center, non-randomized, open-label, parallel, single...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2024-09-20
Trial ID
NCT07625618
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of MY008211A in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12
Trial ID
NCT06134414
Treatments Being Tested
A Concentration-QT Interval Correction (C-QTc) study of MY008211A Tablets i...
Status
Not Yet Recruiting
Location
Peking University Third Hospital
Start Date
2024-08-10
Trial ID
NCT06543459
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of MY008211A com...
Status
Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2024-08-30
Trial ID
NCT06932744
Treatments Being Tested